On October 12, the opening ceremony of the 2021 10th China Innovation and Entrepreneurship Competition Biomedicine National Competition was held in Hangzhou. Since the launch of the competition in June this year, SinoBioPrint has stood out from 4,931 outstanding local enterprises in Shanghai through Shanghai local trials, semi-finals and other competitions. After more than four months of fierce competition, he overcame all obstacles and rushed into the national competition.
Zhang Weixing, Secretary of the Party Committee of the Torch Center of the Ministry of Science and Technology, Sun Xudong, Deputy Secretary of the Party Group and Deputy Director of the Zhejiang Provincial Department of Science and Technology, Xu Weihua, Member of the Standing Committee of the CPC Hangzhou Municipal Committee and Deputy Mayor of Hangzhou Municipal People's Government, Deputy Secretary of the Party Working Committee and Director of the Management Committee of Hangzhou High-tech Zone Li Zhilong and other leaders attended the opening ceremony and delivered speeches.
On October 13, the competition ushered in a peak matchup, with a total of 340 companies from across the country shortlisted. The national competition is divided into 12 groups, each of which is judged by 5 industry experts, investors, etc., and conducts comprehensive professional evaluations in terms of technology, market, team, and finance. SinoBioPrint's "Clinical Transformation of 3D Printing Bionic Cartilage" project stood out with excellent results and won the "Excellent Enterprise" award.
Introduction to the participating projects
3D printed biomimetic osteochondral implants (OCI), referred to as osteochondral scaffolds, are absorbable, cell-free, single-step implantable medical devices for knee, hip, shoulder and ankle joints Treatment of osteochondral injuries of other joints. The osteochondral scaffold is a three-layer structure: the upper layer is the cartilage layer, the middle layer is the transition layer, and the lower layer is the bone layer. The prepared uniform grid-like scaffold. After debridement of the articular cartilage injury, osteochondral stent implantation was performed. Osteochondral scaffold The cartilage layer biomimetic bone and cartilage extracellular matrix (ECM) components can stimulate the migration and differentiation of endogenous bone marrow mesenchymal stem cells (BMSCs), and ultimately promote the regeneration of cartilage tissue in the upper layer of the defect and the formation of cartilage in the lower layer. lower bone. Huaxia Siyin has carried out the implantation test of the osteochondral scaffold for cartilage damage repair in animal disease models, and the results show that the scaffold has good clinical efficacy and medical value.
SinoBioPrint focuses on the clinical translation of 3D bioprinting in the fields of sports medicine, orthopedics and plastic surgery. The company adheres to the values of "focus, excellence, and inclusiveness" in the bio-3D printing technology platform and the innovative medical device track, and contributes to the construction of a healthy China. We look forward to cooperating with upstream and downstream companies, investment and financing companies in a wider range, deeper fields, and higher levels. Welcome to contact and communicate.